Immune response to ORF5a protein immunization is not protective against porcine reproductive and respiratory syndrome virus infection

Veterinary Microbiology

Volumn 164, Issue 3-4, 2013, Pages 281-285

  Robinson, Sally R ^a   Figueiredo, Marina C ^a   Abrahante, Juan E ^a   Murtaugh, Michael P ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Arterivirus; Immunology; Neutralizing antibody; PRRSV; Swine

Indexed keywords

ORF5A PROTEIN; UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN; VIRUS VACCINE;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTERIVIRUS; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNE RESPONSE; IMMUNITY; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME; VIRION; VIRUS ISOLATION;

ANIMALS; ANTIBODY FORMATION; CELL LINE; CELLS, CULTURED; FEMALE; MALE; NEUTRALIZATION TESTS; OPEN READING FRAMES; PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME; PORCINE RESPIRATORY AND REPRODUCTIVE SYNDROME VIRUS; SWINE; VIRAL STRUCTURAL PROTEINS; VIRAL VACCINES;

ANIMALIA; ARTERIVIRUS; PORCINE RESPIRATORY AND REPRODUCTIVE SYNDROME VIRUS; RNA VIRUSES; SUIDAE;

EID: 84877132487     PISSN: 03781135     EISSN: 18732542     Source Type: Journal    
DOI: 10.1016/j.vetmic.2013.03.006     Document Type: Article

References (20)

1. Benson J.E., Yaeger M.J., Lager K.M. Effect of porcine reproductive and respiratory syndrome virus (PRRSV) exposure dose on fetal infection in vaccinated and nonvaccinated swine. Swine Health Prod. 2000, 8:155-160.
2. Berlin B.S., McKinney R.W. A simple device for making emulsified vaccines. J. Lab. Clin. Med. 1958, 52:657-658.
3. Brown E., Lawson S., Welbon C., Gnanandarajah J., Li J., Murtaugh M.P., Nelson E.A., Molina R.M., Zimmerman J.J., Rowland R.R.R., Fang Y. Antibody response to porcine reproductive and respiratory syndrome virus (PRRSV) nonstructural proteins and implications for diagnostic detection and differentiation of PRRSV types I and II. Clin. Vaccine Immunol. 2009, 16:628-635.
4. Cano J.P., Dee S.A., Murtaugh M.P., Pijoan C. Impact of a modified-live porcine reproductive and respiratory syndrome virus vaccine intervention on a population of pigs infected with a heterologous isolate. Vaccine 2007, 25:4382-4391.
5. Cano J.P., Dee S.A., Murtaugh M.P., Trincado C.A., Pijoan C.B. Effect of vaccination with a modified-live porcine reproductive and respiratory syndrome virus vaccine on dynamics of homologous viral infection in pigs. Am. J. Vet. Res. 2007, 68:565-571.
6. Ernst W.A., Kim H.J., Tumpey T.M., Jansen A.D.A., Tai W., Cramer D.V., Adler-Moore J.P., Fujii G. Protection against H1, H5, H6 and H9 influenza A infection with liposomal matrix 2 epitope vaccines. Vaccine 2006, 24:5158-5168.
7. Firth A.E., Zevenhoven-Dobbe J.C., Wills N.M., Go Y.Y., Balasuriya U.B., Atkins J.F., Snijder E.J., Posthuma C.C. Discovery of a small arterivirus gene that overlaps the GP5 coding sequence and is important for virus production. J. Gen. Virol. 2011, 92:1097-1106.
8. Freund J., Thomson K.J. A simple, rapid technique of preparing water-in-oil emulsions of penicillin, drugs and biologics. Science 1945, 101:468-469.
9. Holtkamp D.J., Kliebenstein J.B., Neumann E.J., Zimmerman J.J., Rotto H., Yoder T.K., Wang C., Yeske P., Mowrer C., Haley C. Assessment of the economic impact of porcine reproductive and respiratory syndrome virus on U.S. pork producers. International PRRS Symposium 2011, 86.
10. Johnson C.R., Griggs T.F., Gnanandarajah J., Murtaugh M.P. Novel structural protein in porcine reproductive and respiratory syndrome virus encoded by an alternative ORF5 present in all arteriviruses. J. Gen. Virol. 2011, 92:1107-1116.
11. Johnson C.R., Yu W., Murtaugh M.P. Cross-reactive antibody responses to nsp1 and nsp2 of porcine reproductive and respiratory syndrome virus. J. Gen. Virol. 2007, 88:1184-1195.
12. Li J., Murtaugh M.P. Dissociation of porcine reproductive and respiratory syndrome virus neutralization from antibodies specific to major envelope protein surface epitopes. Virology 2012, 433:367-376.
13. Lopez O.J., Osorio F.A. Role of neutralizing antibodies in PRRSV protective immunity. Vet. Immunol. Immunopathol. 2004, 102:155-163.
14. Mato-Haro V., Cekic C., Martin M., Chilton P.M., Casella C.R., Mitchell T.C. The vaccine adjuvant monophosphoryl lipid A as a TRIF-biased agonist of TLR4. Science 2007, 316:1628-1632.
15. Neumann E.J., Kliebenstein J.B., Johnson C.D., Mabry J.W., Bush E.J., Seitzinger A.H., Green A.L., Zimmerman J.J. Assessment of the economic impact of porcine reproductive and respiratory syndrome on swine production in the United States. J. Am. Vet. Med. Assoc. 2005, 227:385-392.
16. 1-306) vaccine protects against HSV2 genital or rectal infection of female and male mice. Vaccine 2010, 28:548-560.
17. Opriessnig T., Baker R.B., Halbur P.G. Use of an experimental model to test the efficacy of planned exposure to live porcine reproductive and respiratory syndrome virus. Clin. Vaccine Immunol. 2007, 14:1572-1577.
18. Staroscik, A., 2004. Calculator for Determining the Number of Copies of a Template. URI Genomics & Sequencing Center, http://www.uri.edu/research/gsc/resources/cndna.html.
19. Wasilk A., Callahan J.D., Christopher-Hennings J., Gay T.A., Fang Y., Dammen M., Reos M.E., Torremorell M., Polson D., Mellencamp M., Nelson E., Nelson W.M. Detection of U.S., Lelystad, and European-Like porcine reproductive and respiratory syndrome viruses and relative quantitation in boar semen and serum samples by real-time PCR. J. Clin. Microbiol. 2004, 42:4453-4461.
20. Yoon K.J., Zimmerman J.J., Chang C.C., Cancel-Tirado S., Harmon K.M., McGinley M.J. Effect of challenge dose and route on porcine reproductive and respiratory syndrome virus (PRRSV) infection in young swine. Vet. Res. 1999, 30:629-638.